Âé¶¹´«Ã½Ó³»­

Âé¶¹´«Ã½Ó³»­

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Practice Landscape of Lesional Procedures for Movement Disorders in North America
Movement Disorders
Movement Disorders Posters (7:00 AM-5:00 PM)
122

To explore the practice landscape of lesional procedures for Movement disorders in North America

There is a growing interest in incisionless lesional procedures for Movement disorders yet little is known about their practice landscape.

A survey was sent to all members of the Functional Neurosurgical Working Group of the Parkinson’s Study Group (PSG) and American Society for Stereotactic and Functional Neurosurgery (ASSFN). Only one member from each site was asked to fill out the survey.

Thirty eight sites participated, represented by 31 (82%) neurosurgeons, 6 (16%) neurologists and 1 psychiatrist. All patients had preoperative evaluation by neurologists at 82% and by neuropsychologists at 61% of the sites. Postoperatively, all patients were followed by neurologists at the majority of the sites for more than one year. Poor DBS candidacy was the reason for choosing a lesional procedure 75% of the times while patients preferred lesion therapy at other times. MR Guided Focused Ultrasound (MRgFUS) was the most frequently performed procedure but was only offered at a third of the sites. Radiosurgery was available at the majority of the sites yet accounted for significantly smaller number of lesional procedures. Gamma Knife (GK) was three times more widely available than Linear Accelerator Stereotactic Radiosurgery (LINAC). Radiofrequency (RF) ablation was also done by the majority of sites but was used in the fewest number of lesional procedures. Thalamotomy for ET was by far the commonest procedure, and a fourth of the sites reported having done bilateral procedures.  Two thirds of respondents expressed interest in participating in a registry for lesional procedures, and a third expressed possible interest.

This large survey representing major functional neurosurgical sites reports on the current practice landscape of lesional procedures for Movement disorders in North America. This survey can be used to inform registry design and implementation

Authors/Disclosures
Mustafa S. Siddiqui, MD, FÂé¶¹´«Ã½Ó³»­
PRESENTER
Dr. Siddiqui has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Boston Scientific Neuromodulation. Dr. Siddiqui has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. The institution of Dr. Siddiqui has received research support from Boston Scientific Neuromodulation. The institution of Dr. Siddiqui has received research support from Abbvie. The institution of Dr. Siddiqui has received research support from National Institute of Health .
No disclosure on file
No disclosure on file
Joohi Jimenez Shahed, MD, FÂé¶¹´«Ã½Ó³»­ (Icahn School of Medicine at Mount Sinai) Dr. Jimenez Shahed has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. Dr. Jimenez Shahed has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Medtronic. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Jimenez Shahed has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BlueRock. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Treefrog. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Consultant for RebrAIn. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BlueRock Therapeutics. Dr. Jimenez Shahed has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PhotoPharmics. Dr. Jimenez Shahed has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Emalex. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. The institution of Dr. Jimenez Shahed has received research support from Amneal. The institution of Dr. Jimenez Shahed has received research support from Annovis. The institution of Dr. Jimenez Shahed has received research support from SAGE. The institution of Dr. Jimenez Shahed has received research support from Ono Pharmaceuticals. The institution of Dr. Jimenez Shahed has received research support from BlueRock. The institution of Dr. Jimenez Shahed has received research support from Neuron23. Dr. Jimenez Shahed has received personal compensation in the range of $0-$499 for serving as a Faculty with Movement Disorders Society. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Faculty with Âé¶¹´«Ã½Ó³»­. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with Parkinson Foundation.